UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 145

Sortiert nach

Improved Endpoints for Cancer Immunotherapy Trials

JNCI : Journal of the National Cancer Institute, 2010-09, Vol.102 (18), p.1388-1397

2010

Volltextzugriff (PDF)

Response definition criteria for ELISPOT assays revisited

Cancer Immunology, Immunotherapy, 2010-10, Vol.59 (10), p.1489-1501

2010

Volltextzugriff (PDF)

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

Cancer Immunology, Immunotherapy, 2008-03, Vol.57 (3), p.303-315

2008

Volltextzugriff (PDF)

T Cell Assays and MIATA: The Essential Minimum for Maximum Impact

Immunity (Cambridge, Mass.), 2012-07, Vol.37 (1), p.1-2

2012

Volltextzugriff (PDF)

Measurement of cytokine release at the single cell level using the ELISPOT assay

Methods (San Diego, Calif.), 2006-04, Vol.38 (4), p.274-282

2006

Volltextzugriff (PDF)

Toward the harmonization of immune monitoring in clinical trials: Quo vadis?

Cancer Immunology, Immunotherapy, 2008-03, Vol.57 (3), p.285-288

2008

Volltextzugriff (PDF)

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond

Cancer Immunology, Immunotherapy, 2011-01, Vol.60 (1), p.15-22

2011

Volltextzugriff (PDF)

Evaluation of Elispot assays: influence of method and operator on variability of results

Journal of immunological methods, 2004-08, Vol.291 (1), p.175-183

2004

Volltextzugriff (PDF)

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

Journal for immunotherapy of cancer, 2016-11, Vol.4 (1), p.76-76, Article 76

2016

Volltextzugriff (PDF)

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

Journal for Immunotherapy of Cancer, 2016-11, Vol.4 (1), p.77-77, Article 77

2016

Volltextzugriff (PDF)

Phase I Clinical Study for Validation of Fimaporfin-Based Photochemical Internalisation: A Novel Technology for Enhancing Cellular Immune Responses Important for Therapeutic Effect of Peptide-and Protein-Based Vaccines

Annals of oncology, 2019-12, Vol.30, p.xi40-xi41

2019

Volltextzugriff (PDF)

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

Journal of immunological methods, 2002-02, Vol.260 (1), p.157-172

2002

Volltextzugriff (PDF)

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

Cancer Immunology, Immunotherapy, 2009-10, Vol.58 (10), p.1701-1713

2009

Volltextzugriff (PDF)

Immunization of cancer patients with autologous cancer‐derived heat shock protein gp96 preparations: A pilot study

International journal of cancer, 2000-10, Vol.88 (2), p.232-238

2000

Volltextzugriff (PDF)

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays

Cancer Immunology, Immunotherapy, 2008-03, Vol.57 (3), p.289-302

2008

Volltextzugriff (PDF)

Detection And ex vivo Expansion Of Dormant Anti-Viral CTL Precursors Isolated From Recipients Of Unrelated Umbilical Cord Blood Transplant (UCBT)

Biology of blood and marrow transplantation, 2010, Vol.16 (2), p.S167-S168

2010

Volltextzugriff (PDF)

Training in immunology of relevance to global health issues in resource poor settings

European journal of immunology, 2010-05, Vol.40 (5), p.1228-1231

2010

Volltextzugriff (PDF)

A new hotspot for cancer immunotherapy?

The cancer journal from Scientific American, 1998-09, Vol.4 (5), p.298

1998

Volltextzugriff (PDF)

Evaluation of CD8+ T‐cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

International journal of cancer, 2000-08, Vol.87 (3), p.391-398

2000

Volltextzugriff (PDF)

The role of the reporting framework MIATA within current efforts to advance immune monitoring

Journal of immunological methods, 2014-07, Vol.409, p.6-8

2014

Volltextzugriff (PDF)

The complete sequence of the rabbit erythroid cell-specific 15-lipoxygenase mRNA: comparison of the predicted amino acid sequence of the erythrocyte lipoxygenase with other lipoxygenases

Gene, 1989-06, Vol.79 (1), p.181-188

1989

Volltextzugriff (PDF)

Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96

Journal of immunotherapy, 1998-07, Vol.21 (4), p.269-276

1998

Volltextzugriff (PDF)

MHC Polymorphism Can Enrich the T Cell Repertoire of the Species by Shifts in Intrathymic Selection

The Journal of immunology (1950), 2000-02, Vol.164 (4), p.1695-1698

2000

Volltextzugriff (PDF)

Heat shock protein vaccines against cancer

Journal of immunotherapy with emphasis on tumor immunology, 1993-11, Vol.14 (4), p.352

1993

Volltextzugriff (PDF)

Insect cells as HLA-restricted antigen-presenting cells for the IFN-γ Elispot assay

Journal of immunological methods, 2000-02, Vol.234 (1), p.1-12

2000

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Englisch
(143)
Japanisch
(21)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(78)
Humans
(53)
Immunology
(45)
Biological And Medical Sciences
(24)
Immunotherapy
(22)
Animals
(21)
Oncology
(21)
Medical Sciences
(17)
Biochemistry & Molecular Biology
(16)
Reproducibility Of Results
(16)
Elispot
(15)
T-Lymphocytes - Immunology
(13)
Biochemical Research Methods
(12)
Cellular Biology
(12)
Medical Laboratory Testing & Techniques
(12)
Medicine
(12)
Neoplasms - Therapy
(12)
Physical Sciences
(12)
Elispot Assay
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Improved Endpoints for Cancer Immunotherapy Trials

Response definition criteria for ELISPOT assays revisited

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

T Cell Assays and MIATA: The Essential Minimum for Maximum Impact

Measurement of cytokine release at the single cell level using the ELISPOT assay

Toward the harmonization of immune monitoring in clinical trials: Quo vadis?

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond

Evaluation of Elispot assays: influence of method and operator on variability of results

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

Phase I Clinical Study for Validation of Fimaporfin-Based Photochemical Internalisation: A Novel Technology for Enhancing Cellular Immune Responses Important for Therapeutic Effect of Peptide-and Protein-Based Vaccines

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

Immunization of cancer patients with autologous cancer‐derived heat shock protein gp96 preparations: A pilot study

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays

Detection And ex vivo Expansion Of Dormant Anti-Viral CTL Precursors Isolated From Recipients Of Unrelated Umbilical Cord Blood Transplant (UCBT)

Training in immunology of relevance to global health issues in resource poor settings

A new hotspot for cancer immunotherapy?

Evaluation of CD8+ T‐cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

The role of the reporting framework MIATA within current efforts to advance immune monitoring

The complete sequence of the rabbit erythroid cell-specific 15-lipoxygenase mRNA: comparison of the predicted amino acid sequence of the erythrocyte lipoxygenase with other lipoxygenases

Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96

MHC Polymorphism Can Enrich the T Cell Repertoire of the Species by Shifts in Intrathymic Selection

Heat shock protein vaccines against cancer

Insect cells as HLA-restricted antigen-presenting cells for the IFN-γ Elispot assay

Suchergebnisse filtern